IVVD
Invivyd, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.83
−1.08%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.34x
- Price / sales
- 4.17x
- Price / cash flow
- -2.25x
Enterprise value
- Enterprise value
- $91.8M
- EV / sales
- 1.57x
- EV / EBITDA
- -0.86x
- EV / EBIT
- -0.82x
- Market cap
- $243.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026